Brains Bioceutical Corp: Prati-Donaduzzi Secures the Largest Global Pharma Supply Agreement for Natural Cannabinoids with API Manufacturer Brains Bioceutical

VANCOUVER, British Columbia, April 04, 2023 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp ("Brains Bio" or the "Company"), the largest natural cannabinoid active pharmaceutical ingredient ("API") manufacturer

Related Keywords

United Kingdom ,Brazil ,Vancouver ,British Columbia ,Canada ,United States ,Grand View ,Manitoba ,British ,America ,American ,Ricky Brar ,Eder Fernado Maffissoni ,Brazil Health Regulatory Agency ,View Research ,Brains Bioceutical Corp ,Linkedin ,Instagram ,Brains Bioceutical Corp Bio ,Twitter ,Bioceutical Corp ,South America ,Nacional De Vigil ,Health Regulatory ,Brains Bio ,South American ,Eder Fernado Maffissoni President ,Brains Bioceutical ,Grade Licensed Cannabinoid Research ,Commercial Production Facility ,Capital Raise ,Lead Investor ,Grand View Research ,Market Size ,Trends Analysis Report By Product Type ,Segment Forecasts ,Brains ,Ioceutical ,Orp ,Mirati ,Onaduzzi ,Ecures ,Largest ,Lobal ,Dharma ,Supply ,Agreement ,Natural ,Cannabinoids ,Manufacturer ,